Industry Insight

The curated BIO-Europe Spring programme brings together a powerhouse of thought leaders and features the innovative spirit of the life sciences community. Here is a sneak peek at what to expect

Day in the life of an experienced dealmaker

Join leading pharma and venture investors and unravel strategies for navigating the current dealmaking landscape. Uncover trends, actionable insights and key considerations for building successful partnerships, along with the tools to thrive in today’s competitive environment to drive impactful collaborations.

Restoring the picture: a new era in oncology

Explore the advancing oncology landscape, with its multiple innovation areas and partnerships. Delve into the emerging therapies, latest breakthroughs in precision medicine and recent deals, along with addressing the shortcomings, enabling to redefine the future of cancer treatment.

The art of storytelling in collaboration with the YVC Collective: ‘Narrative vs science – How can young entrepreneurs and investors empower biotech storytelling?‘

European biotechs often encounter difficulties in crafting narratives that capture investor interest as effectively as their US counterparts. Opening questions include:

• How can young CEOs cultivate storytelling skills that resonate with both European and global investors?

• How can young investors support biotechs to craft authentic narratives without losing scientific rigour?

Runway to pharma’s future: VCs on forecasting game-changing science

As pharma reshapes its pipelines to keep pace with market needs and scientific breakthroughs, venture capitalists (VCs) play a pivotal role in identifying the next wave of transformative therapies. Drawing inspiration from Milan’s legacy of trendsetting in fashion and art, this panel explores how VCs forecast what pharma will need in five years’ time. What defines game-changing science, and how can investors distinguish the breakthroughs that will set the future stage? Panelists will share their strategies for search and evaluation, reveal what truly stands out to pharma, and discuss how aligning innovation with pharma’s evolving priorities can create a lasting impact.

Join us for insightful discussions on shaping a future that redefines the industry.